about
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studiesA Smartphone Application Supporting Recovery from Heroin Addiction: Perspectives of Patients and Providers in China, Taiwan, and the USASpiritual Well-Being and Associated Factors with Relapse in Opioid Addicts.Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006-10.Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX).Gender differences in mortality among treated opioid dependent patients.Technological aids for improving longitudinal research on substance use disorders.The CHANGE Study: Methods and Sample Description for a Cross-Sectional Study of Heroin Cessation in New York City.Gender differences in recovery consequences among heroin dependent patients after compulsory treatment programs.Chronic pain among patients with opioid use disorder: Results from electronic health records data.The Key to Individualized Addiction Treatment is Comprehensive Assessment and Monitoring of Symptoms and Behavioral Change.Nonmedical opioid use and heroin use in a nationally representative sample of us high school seniorsLong-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trialThe Future of Opioid Agonist Therapies in Ukraine: A Qualitative Assessment of Multilevel Barriers and Ways Forward to Promote Retention in Treatment.Feasibility of a Supportive Other Intervention for Opiate-Dependent Patients Entering Inpatient Detoxification.Buprenorphine implants in medical treatment of opioid addiction.High Mortality Among Patients With Opioid Use Disorder in a Large Healthcare System.Six-Year Outcome of Opioid Maintenance Treatment in Heroin-Dependent Patients: Results from a Naturalistic Study in a Nationally Representative Sample.Estimating State Transitions for Opioid Use Disorders.Innovative Technology Using Virtual Reality in the Treatment of Pain: Does It Reduce Pain via Distraction, or Is There More to It?Distinctive Trajectories of Opioid Use Over an Extended Follow-up of Patients in a Multisite Trial on Buprenorphine + Naloxone and Methadone.Characteristics and response to treatment among Indigenous people receiving injectable diacetylmorphine or hydromorphone in a randomised controlled trial for the treatment of long-term opioid dependence.Opioid Therapy for Chronic Pain: Overview of the 2017 US Department of Veterans Affairs and US Department of Defense Clinical Practice Guideline.Treatment of opioid dependence with buprenorphine: current update.Ondansetron does not prevent physical dependence in patients taking opioid medications chronically for pain control.Psychosocial interventions in opiate substitution treatment services: does the evidence provide a case for optimism or nihilism?Older Former Prisoners' Pathways to Sobriety.Linking Individuals with Substance Use Disorders (SUDs) in Primary Care to SUD Treatment: the Recovery Management Checkups-Primary Care (RMC-PC) Pilot Study.Integrated Models of Care for Individuals with Opioid Use Disorder: How Do We Prevent HIV and HCV?Preventing Opioid Overdose in the Clinic and Hospital: Analgesia and Opioid Antagonists
P2860
Q30234647-D8A78A72-7422-43D8-ACE8-0B95BFA7B63BQ33447050-18B327B5-7CE1-4AB4-903D-21395AF61D70Q33666935-D873DAEB-A968-4C82-A126-FCDA967C1A9DQ35674032-6A0CCDFD-DD53-49E0-AE60-E5C45CA22FD5Q36001217-9CE3A827-F8BF-4BF0-991F-507A755D5A37Q36090298-8F3F7A17-BB5E-4503-8766-EDDEB03FAA26Q36100544-3B98F977-F941-49E2-89D2-59A06A6DC272Q36171453-6C5DAA7D-2EB4-4C47-9FAD-CE134D161804Q36353551-206BEE9D-F7E4-446C-81EE-E3F7C435E964Q36364566-9F0F4045-BD8F-454F-B3CF-B4C754F7DA87Q36415984-C201360F-3282-4828-A165-56B9A03BA9FEQ36421383-26213106-3BB0-41D5-839E-2A60C34A84DFQ36711893-3F7BFDA9-803E-4BEF-A3ED-1596FCE046E7Q37035765-8CF52AFF-5037-4484-89A8-1D350DAD55FAQ37192631-37873EDE-A754-457E-AB4A-4BB622500F2CQ38750450-3F338877-7B4A-4F75-A9D0-944191728989Q38828696-28629218-5607-4245-976B-2A94CD3712B1Q38855420-322CB543-AF4D-49F3-AD8A-0665498A3FF4Q39062397-BF38266C-682E-4AEB-B4CA-C1C127A38C57Q43075814-AC8A8A84-5859-464F-BF26-077ECBF13358Q44341673-F6E7BF70-870F-46F1-BEFF-39BC293227ACQ44346325-EFDD3FFA-7385-4114-83DD-11EADE4F7968Q44349732-F454F98D-C8B9-4F25-BA70-81814C573901Q47133543-B5440B74-49C4-48ED-8956-3ABB1761BC66Q47217585-CC82C159-70DC-40B8-B23B-8BE3246CABA9Q47357594-06CDD400-A01E-4A3B-B39B-739AD2B7760AQ49364544-D5CFC597-48FF-41E6-9F18-62C61CF78E31Q49579899-8AE45B0B-6BE8-48DA-9F51-06A98A78522DQ55425578-38C23910-0ECE-491D-AE3F-164395DDADC4Q57128664-0BA56DDE-088B-4DA5-9EEA-8494D300201B
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Long-term course of opioid addiction.
@en
type
label
Long-term course of opioid addiction.
@en
prefLabel
Long-term course of opioid addiction.
@en
P2093
P1476
Long-term course of opioid addiction.
@en
P2093
Christine Grella
Douglas Anglin
Walter Ling
Yih-Ing Hser
P356
10.1097/HRP.0000000000000052
P577
2015-03-01T00:00:00Z